In the group of five articles that included exclusively HER2 negative cases (0, 1+ and 2+/ISH-) [18, 19, 24–26], data on histological type were available from two articles [18, 26], indicating a prevalence of 86.9% for ductal carcinoma. Here, ERBB2 is linked to breast ductal adenocarcinoma.